U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: Compliance with Providing an Acceptable Unique Facility Identifier for the Foreign Supplier Verification Programs for Food Importers Regulation
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: Compliance with Providing an Acceptable Unique Facility Identifier for the Foreign Supplier Verification Programs for Food Importers Regulation April 2022

Final
Docket Number:
FDA-2011-N-0143
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine
Center for Food Safety and Applied Nutrition

This guidance provides information on the requirement under the Foreign Supplier Verification Programs for Food Importers (FSVP) regulation for the importer of a food to ensure that for each entry line of food offered for importation into the United States the unique facility identifier (UFI) recognized as acceptable by FDA for importer identification is provided electronically when filing entry with U.S. Customs and Border Protection (CBP). The UFI initially recognized as acceptable by FDA for importer identification is a Dun & Bradstreet (D&B) Data Universal Numbering System (DUNS) number. The pronoun “you” is used in this guidance to refer to the FSVP importer as defined in the FSVP regulation (21 CFR 1.500).

This guidance replaces FDA’s “Compliance with Providing an Acceptable Unique Facility Identifier for the Foreign Supplier Verification Programs Regulation: Guidance for Industry” issued March 2018.  

The March 2018 guidance provided for the temporary use of the entity role code “UNK” (to represent “unknown”) in lieu of a DUNS number, to be provided in the Entity Number field for importer identification when filing entry with CBP for a food subject to FSVP.  FDA explained that while the agency expected all importers to provide their UFI in accordance with 21 CFR 1.509(a), the agency recognized that this was a new requirement and some factors may have prevented importers from doing so.  Therefore, FDA provided that for FSVP importers temporarily unable to obtain a DUNS number, FDA intended to allow filers to transmit the value “UNK” in the UFI field for the FSVP importers.   

This guidance updates the March 2018 guidance by removing the temporary policy of permitting the use of the entity role code “UNK” in lieu of a DUNs number.  Needs and circumstances have changed since FDA announced its temporary policy, as FSVP importers have now had ample time to familiarize themselves with the requirements in 21 CFR 1.509(a).  Accordingly, beginning on July 24, 2022, FSVP importers must comply with the requirement in 21 CFR 1.509(a) of providing a unique facility identifier recognized as acceptable by FDA when filing entry with CBP.  This guidance also provides additional information for what importers should do when they have multiple DUNS numbers.

Beginning July 24, 2022, the use of the entity identification code “UNK” will no longer be an option.  Consistent with 21 CFR 1.509(a), the FSVP importer will be required to ensure that their valid, 9-digit DUNS number is provided in the Entity Number field.  CBP will reject an entry line of a food subject to the FSVP regulation when the importer’s DUNS number is not provided in the Entity Number field.

The contents of this document do not have the force and effect of law and are not meant to bind the public in any way, unless specifically incorporated into a contract. This document is intended only to provide clarity to the public regarding existing requirements under the law. FDA’s guidance documents, including this guidance, should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidance means that something is suggested or recommended, but not required.

Download the Guidance


Related Information


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2011-N-0143.

 
Back to Top